about
Advances in hepatitis E - I: virology, pathogenesis and diagnosis.Advances in hepatitis E - II: Epidemiology, clinical manifestations, treatment and prevention.Indian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection: Update 2016.Non-cirrhotic portal fibrosis at a tertiary care centre in South India.Cost-effectiveness of hepatitis C treatment using generic direct-acting antivirals available in IndiaSerum liver enzyme pattern in birth asphyxia associated liver injuryChanges in gene expression in liver tissue from patients with fulminant hepatitis E.Pancreatic diabetes.Gut microbiota and liver disease.Cryptosporidium infection after renal transplantation in an endemic area.Hepatitis A: epidemiology in resource-poor countries.Treatment of chronic genotype-3 hepatitis C virus infection using direct-acting antiviral agents: An Indian experience.Experience with direct acting anti-viral agents for treating hepatitis C virus infection in renal transplant recipients.Safety and effectiveness of response-guided therapy using pegylated interferon and ribavirin for chronic hepatitis C virus infection in patients on maintenance dialysis.Prevalence, severity, and impact on quality of life of restless leg syndrome in patients with liver cirrhosis in India.Prevalence of hepatitis D virus infection among hepatitis B virus-infected individuals in India.Lack of persistent hepatitis E virus infection as a cause for unexplained transaminase elevation in renal transplant recipients in India.Cholestatic presentation of yellow phosphorus poisoning.Corrigendum to "Indian National Association for Study of the Liver (INASL) guidance for antiviral therapy against HCV infection: Update 2016" [J. Clin. Exp. Hepatol. 6 (2016) 119-145].Iron deficiency anemia and Plummer-Vinson syndrome: current insights.Ascitic form of sporadic acute viral hepatitis in children: a distinct entity for recognition.Unconjugated hyperbilirubinemia: a blessing in disguise?Screening Transfusions for Hepatitis E Virus: Is it needed in India?Faecal bacterial microbiota in patients with cirrhosis and the effect of lactulose administration.Evaluation of cognitivity, proinflammatory cytokines, and brain magnetic resonance imaging in minimal hepatic encephalopathy induced by cirrhosis and extrahepatic portal vein obstruction.Frequency and factors associated with small intestinal bacterial overgrowth in patients with cirrhosis of the liver and extra hepatic portal venous obstruction.Daclatasvir and reduced-dose sofosbuvir: an effective and pangenotypic treatment for hepatitis C in patients with eGFR <30 ml/min.Translation and validation of chronic liver disease questionnaire (CLDQ) in Tamil language.Histological and immunohistochemical features in fatal acute fulminant hepatitis E.Acute hepatitis E in India appears to be caused exclusively by genotype 1 hepatitis E virus.Endoscopic ultrasound-guided choledochoduodenostomy using partially-covered self-expandable metal stent in patients with malignant distal biliary obstruction and unsuccessful ERCP.Natural History, Clinical Manifestations, and Pathogenesis of Hepatitis E Virus Genotype 1 and 2 Infections.Effect of administration of a probiotic preparation on gut microbiota and immune response in healthy women in India: an open-label, single-arm pilot study.Endoscopic ultrasound-guided coil and glue for treatment of splenic artery pseudo-aneurysm: new kid on the block!Hepatitis EBurden of hepatitis C virus infection in India: A systematic review and meta-analysisPrevalence of hepatitis E virus viremia and antibodies among healthy blood donors in IndiaCost-effectiveness of generic pan-genotypic sofosbuvir/velpatasvir versus genotype-dependent direct-acting antivirals for hepatitis C treatmentGenotyping of hepatitis B virus isolates from Lahaul and Spiti district in Himachal Pradesh, IndiaHepatitis B vaccine: Using skin when muscle does not work
P50
Q30250366-1819F90B-A32E-4295-A94B-E3CFD39C3245Q30251421-2B51E3A3-5DBD-4E03-8451-2EF3E707424FQ30355190-E5413DEF-2E06-4EA3-BF68-838F72287536Q33430823-F6E720A5-C72E-410B-B5C7-1C3AF03B2C42Q33698956-AD9E665A-7831-441E-AC69-85920D44E22CQ34403851-9616A95F-E647-4992-83C6-5373E14C88BBQ35843030-CEE26500-0D07-4BCC-8D89-21A109291CC3Q37598826-A7B22114-42C0-4BD8-8171-2C13FE66D0CFQ38189120-B0B5A470-68D1-4C04-8E6D-DAA5223392BCQ38332100-C9189E01-34CA-4215-A100-9C1EE936EE32Q38552676-2DE4481E-B9CC-4BBB-815B-2BBBBCAE6649Q40143151-708A9951-A9D4-4D01-BD53-0432D28491DEQ40272838-22F6B030-1F80-40F8-9AF7-850DE9596EA9Q40707781-CE71A103-3057-4163-B981-77CAAB2E9BF8Q40735570-9955FFCA-E227-4ABA-A56F-50DD005BBDA2Q41028301-F77EBEA2-3F99-4AAA-8686-E43FC9A30719Q41722633-5E7BFF04-C7B8-4247-96BA-F2E5C56BEFA3Q41929172-F5B972C0-FFB7-47F1-A7F4-A5DB1B49D1AFQ42372776-F826D44A-AF3C-4AD4-B243-14EE7E513AA8Q43193897-8749A6AF-ED71-44F2-AD3D-D50EA677D018Q43228561-09AE0ED2-7E4C-4406-A5C1-AD5E375229ABQ43525854-E0785CA4-7642-40F8-AE95-63822FE1143DQ45336543-C072F437-4094-42D6-9C98-AD5935B44C4BQ46253420-80F83E14-24CE-481D-8891-04641DE558CDQ46446657-84AAAAA7-0FF8-4409-BA7F-87A1491637D7Q46981637-04DFBDBB-F53D-4FAA-90B9-6C50C0E3F325Q47554654-848F3BA3-80FE-47AC-ACA6-9477FBB7D34EQ47558563-CD1383C6-C1A9-457F-887C-B98B9A877950Q47909263-B22C6F60-DE5E-41BA-B230-9FDC717D782CQ48108650-0B956226-DCC0-4D81-9B16-87581397332FQ49890481-2B79EC92-93D4-4E2F-A67E-3A932E65C532Q54218937-F707CC67-8B24-49DD-9BAF-3315BFCCC867Q55363098-A9664EFA-9064-4CD2-8387-A9337B0EA9E0Q55519552-73A0D462-F02A-4518-BFEA-18F7F2AB5840Q56460549-35587E62-EE80-4832-8764-7BADD041F635Q57071323-76CF33C1-D372-400E-8D33-77EC9E168FCEQ57071327-90FF9F11-DB54-4A25-8017-F61E8BFB4DE1Q57071335-AEA5F5E6-2BC4-48A3-803E-AE36BF75F8B9Q57071340-F2B46292-A5EC-419C-95CC-DC916A3A7BFEQ57071372-30A7DBAD-7204-4709-AC33-F4BE1264487F
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0003-3525-9381
@en
name
Amit Goel
@ast
Amit Goel
@en
Amit Goel
@es
Amit Goel
@nl
অমিত গোয়েল
@bn
type
label
Amit Goel
@ast
Amit Goel
@en
Amit Goel
@es
Amit Goel
@nl
অমিত গোয়েল
@bn
prefLabel
Amit Goel
@ast
Amit Goel
@en
Amit Goel
@es
Amit Goel
@nl
অমিত গোয়েল
@bn
P106
P31
P496
0000-0003-3525-9381